Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

REACH

Sodium methanesulphonate

EC number: 219-203-2 | CAS number: 2386-57-4

Life Cycle description
Uses advised against

Toxicological information

Endpoint summary

Administrative data

Description of key information

Acute oral toxicity

The single-dose oral toxicity study with Sodium methanesulfonate was performed according to the acute toxic class method (OECD 423 and Commission Regulation (EC) No 440/2008 of 30 May 2008, B.1.Tris) in Crl:WI rats.

Two groups of three female Crl:WI rats were treated with the test item at a dose level of 2000 mg/kg bw (Group 1 and Group 2). A single oral treatment was carried out by gavage for each animal after an overnight food withdrawal. Food was made available again 3 hours after the treatment. The test item was administered at the dose level of 2000 mg/kg body weight (equivalent to 4.23 mL/kg bw of SPS10LS). Initially, three females (Group 1) were treated at a dose level of 2000 mg/kg bw. As no mortality was observed, a confirmatory group (Group 2) was treated at the same dose level. No mortality was observed in the confirmatory group; therefore no further testing was required according to OECD 423 and Commission Regulation (EC) NO 440/2008 of 30 May 2008, B.1.Tris. Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Body weight was measured on Days -1, 0, 7 and before necropsy (Day 14). All animals were subjected to a necropsy and a macroscopic examination.

Sodium methanesulfonate did not cause mortality at a dose level of 2000 mg/kg bw. All animals were symptom free during the study. Body weight gains of Sodium methanesulfonate treated animals during the study showed no indication of a test item-related effect. There was no evidence of the macroscopic observations at a dose level of 2000 mg/kg bw.

Under the conditions of this study, the acute oral LD0 value of the test item Sodium methanesulfonate was found to be equal to or above 2000 mg/kg bw in female Crl:WI rats.

Acute dermal toxicity

An acute dermal toxicity study was performed with test item Sodium methanesulfonate in Crl:WI rats, in compliance with OECD Guideline No.: 402. A limit test was carried out at 2000 mg Sodium methanesulfonate/kg body weight (equivalent to 4.23 mL/kg bw of SPS10LS) in both sexes (5 rats/sex). The test item was applied as a single dermal 24-hour exposure followed by a 14-day observation period. Clinical observations were performed on all animals at 1 and 5 hours after dosing and daily for 14 days thereafter. Body weight was measured prior to dosing on Day 0 and on Days 7 and 14. Gross macroscopic examination was performed on all animals at the end of the 2-week observation period (Day 14).

Sodium methanesulfonate did not cause mortality at the dose level of 2000 mg/kg bw. There were no systemic clinical signs noted in any animal throughout the study. No local dermal signs were observed after treatment with the test item during the 14 days observation period. Body weight gains of Sodium methanesulfonate treated animals during the study showed no indication of a test item-related effect.There was no evidence of the macroscopic observations at a dose level of 2000 mg/kg bw.

Under the conditions of this study, the acute dermal lethal dose (LD0 value) of the test item Sodium methanesulfonate was found to be equal to or above 2000 mg/kg bw in male and female Crl:WI rats.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Reference

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

28 July 2016 to 12 August 2016

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)

Version / remarks:

OECD Guidelines for Testing of Chemicals No. 423. Acute Oral Toxicity – Acute Toxic Class Method. Adopted: 17 December 2001

Deviations:

yes

Remarks:

see "Any other information" for details

GLP compliance:

yes (incl. QA statement)

Test type:

acute toxic class method

Limit test:

yes

Species:

rat

Strain:

Wistar

Sex:

female

Details on test animals or test system and environmental conditions:

Species and strain: Crl:WI Wistar rats
Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, D-97633 Sulzfeld
Hygienic level at arrival: SPF
Hygienic level during the study: Standard housing conditions
Number of animals: 6 animals, 3 animals/group
Sex: Female, nulliparous and non-pregnant
Age of animals at dosing: Young healthy adult rats, 8 weeks old
Body weight at treatment: 186 – 190 g
Acclimatization period: 7-8 days
HusbandryAnimal health: Only healthy animals were used for the test. The health status was certified by the staff Veterinarian.Number of animal room: 245/4
Housing: 3 animals / cage
Cage type: Type II. polypropylene/polycarbonate
Bedding: Lignocel 3/4-S Hygienic Animal Bedding” produced by J. Rettenmaier & Söhne GmbH +Co.KG (D-73494 Rosenberg, Germany) was available to animals during the study.
Nesting: Arbocel crinklets natural produced by J. Rettenmaier & Söhne GmbH + Co.KG (D-73494 Rosenberg, Germany) was available to animals during the study.
Lighting period: 12 hours daily, from 6.00 a.m. to 6.00 p.m.
Temperature: 19.7 – 24.7 °C
Relative humidity: 31 - 77%
Ventilation: 15-20 air exchanges/hour
Enrichment: Animals were housed by group to allow social interaction and with deep wood sawdust bedding to allow digging and other normal rodent activities.The temperature and relative humidity were recorded twice daily during the acclimatisation period and throughout the study.
Food and Water Supply: Animals received ssniff® SM R/M "Autoclavable complete diet for rats and mice – breeding and maintenance" produced by ssniff Spezialdiäten GmbH, D-59494 Soest Germany (batch number: 278 5652, expiry date: 31 October 2016), ad libitum, and tap water from the municipal supply, as for human consumption from a 500 ml bottle, ad libitum.
Animal Identification: Animals were individually identified using numbers written on the tail with an indelible marker pen. The numbers were given on the basis of CiToxLAB Hungary Ltd.' S Master File, for each animal allocated to the treatment groups. The cages were identified by cards, with information about study code, sex, dose group, cage number and individual animal numbers.

Route of administration:

oral: gavage

Vehicle:

unchanged (no vehicle)

Details on oral exposure:

The test item was administered as a single dose without using any vehicle.Justification of the dose:The initial dose level was selected by the Study Director to be that which is most likely to produce mortality in some of the dosed animals. In the lack of any preliminary toxicological information, 2000 mg/kg bw was selected to be the starting dose (equivalent to 4.23 mL/kg bw of SPS10LS, based on the analytics performed on 27 May 2016).Initially, three female animals were treated with 2000 mg/kg bw of the test item. No mortality was observed, therefore further 3 animals were treated at the dose level of 2000 mg/kg bw. As no mortality was observed in this second dose group, further testing was not required according to the test guidelines (OECD 423, Commission Regulation (EC) NO 440/2008 of 30 May 2008, B.1.Tris).

Doses:

A single oral treatment was carried out by gavage for each animal. The test item was administered at the dose level of 2000 mg/kg body weight (equivalent to 4.23 mL/kg bw of SPS10LS).

No. of animals per sex per dose:

Initially, three females (Group 1) were treated at a dose level of 2000 mg/kg bw. A confirmatory group of three females (Group 2) was treated at the same dose level.

Control animals:

Details on study design:

Procedure
A single oral gavage administration was followed by a 14-day observation period. On the night before treatment, the animals were fasted. The food but not water was withheld during an overnight period. Animals were weighed just before treatment. The test item was administered by oral gavage in the morning. The food was returned 3 hours after the treatment.

OBSERVATIONS
Clinical Observations
Clinical observations were performed on all animals at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Individual observations were performed on the skin, fur, eyes, mucous membranes, respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
Body Weight Measurement
The body weight was recorded on the day before treatment (Day -1), on the day of the treatment (Day 0) and weekly Thereafter.

NECROPSY
Macroscopic examination was performed on all animals. The animals were sacrificed by exsanguination under pentobarbital anaesthesia (Euthanimal 40%; Lot No.: 1409236-06, Expiry Date: September 2017, Produced by: AlfasanNederland BV, Woerden, Netherlands). After examination of the external appearance, the cranial, thoracic and the abdominal cavities were opened and the organs and the tissues were observed. Macroscopic abnormalities were recorded.

Statistics:

Not specified

Key result

Sex:

female

Dose descriptor:

LD0

Effect level:

>= 2 000 mg/kg bw

Based on:

test mat.

Mortality:

Sodium methanesulfonate did not cause mortality at a dose level of 2000 mg/kg bw.

Clinical signs:

All animals were symptom free during the study.

Body weight:

Body weight gains of Sodium methanesulfonate treated animals during the study showed no indication of a test item-related effect.

Gross pathology:

There was no evidence of the macroscopic observations at a dose level of 2000 mg/kg bw.

Other findings:

No further findings specified in the study report.

CLINICAL OBSERVATIONS

DOSE LEVEL: 2000 mg/kg bw, Treatment on Day 0 SEX: Female

Cage No.

Animal Number

Observations

Observation days

Frequency

7-14

30’

1945

Symptom Free

20/20

1946

Symptom Free

20/20

1947

Symptom Free

20/20

1948

Symptom Free

20/20

1949

Symptom Free

20/20

1950

Symptom Free

20/20

Remarks:

+ = present

h = hour ‘ = minute

Frequency of observation = number of occurrence of observation/ total number of observations

BODY WEIGHT DATA

DOSE LEVEL: 2000 mg/kg bw, Treatment on Day 0 SEX: Female

Cage No.	Animal Number	Body Weight (g) Days				Body Weight Gain (g)
Cage No.	Animal Number	-1	0	7	14	-1 – 0	0 – 7	7 – 14	-1 – 14
1	1945	200	186	228	248	-14	42	20	48
	1946	204	190	228	253	-14	38	25	49
	1947	203	189	225	251	-14	36	26	48
2	1948	197	187	222	242	-10	25	20	45
	1949	203	188	240	255	-15	52	15	52
	1950	205	190	235	239	-15	45	4	34
Mean:		202.0	188.3	229.7	248.0	-13.7	41.3	18.3	46.0
Standard deviation:		3.0	1.6	6.7	6.3	1.9	6.4	8.1	6.3

NECROPSY FINDINGS

DOSE LEVEL: 2000 mg/kg bw, Treatment on Day 0 SEX: Female

Cage No.	Animal Number	Necropsy Date/ Necropsy Day	External Observations	Internal Observations	Organ/Tissue
1	1945	11 August 2016 Day 14	No external observations recorded	No internal observations recorded	Not applicable
	1946	11 August 2016 Day 14	No external observations recorded	No internal observations recorded	Not applicable
	1947	11 August 2016 Day 14	No external observations recorded	No internal observations recorded	Not applicable
2	1948	12 August 2016 Day 14	No external observations recorded	No internal observations recorded	Not applicable
	1949	12 August 2016 Day 14	No external observations recorded	No internal observations recorded	Not applicable
	1950	12 August 2016 Day 14	No external observations recorded	No internal observations recorded	Not applicable

Interpretation of results:

GHS criteria not met

Conclusions:

The acute oral LD0 value of the test item Sodium methanesulfonate was found to be equal to or above 2000 mg/kg bw in female Crl:WI rats.

Executive summary:

Under the conditions of this study, the acute oral LD0 value of the test item Sodium methanesulfonate was found to be equal to or above 2000 mg/kg bw in female Crl:WI rats.

Endpoint conclusion

Endpoint conclusion:: no adverse effect observed
Dose descriptor:: discriminating dose
Value:: 2 000 mg/kg bw

Acute toxicity: via inhalation route

Endpoint conclusion

Endpoint conclusion:: no study available

Acute toxicity: via dermal route

Link to relevant study records

Reference

Endpoint:

acute toxicity: dermal

Type of information:

experimental study

Adequacy of study:

key study

Study period:

19 July 2016 to 02 August 2016

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 402 (Acute Dermal Toxicity)

Version / remarks:

OECD Guidelines for Testing of Chemicals No. 402. Acute Oral Toxicity – Acute Toxic Class Method. Adopted: 24 February 1987

Deviations:

yes

Remarks:

See "Any other information" for details

GLP compliance:

yes (incl. QA statement)

Test type:

fixed dose procedure

Limit test:

yes

Species:

rat

Strain:

Wistar

Sex:

male/female

Details on test animals or test system and environmental conditions:

Species and strain: Crl:WI Wistar rats
Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, D-97633 Sulzfeld
Hygienic level at arrival: SPF
Hygienic level during the study: Standard housing conditions
Number of animals: 5 animals/sex
Sex: Male and female, female rats were nulliparous and non-pregnant
Age of animals at dosing: Young healthy adult rats
Body weight at treatment: Between 217 g and 250 g
Acclimatization period: 5 days
HusbandryAnimal health: Only healthy animals were used for the test. The health status was certified by the staff Veterinarian.Number of animal room: 245/9
Housing: Individual caging
Cage type: Type II. polypropylene/polycarbonate
Bedding: “Lignocel 3/4-S Hygienic Animal Bedding” and “Arbocel crinklets natural” nest building material produced by J. Rettenmaier & Söhne GmbH & Co.KG (D-73494 Rosenberg, Germany) was available to animals during the study.
Lighting period: 12 hours daily, from 6.00 a.m. to 6.00 p.m.
Temperature: 20.8 – 24.8 °C
Relative humidity: 35 – 80%
Ventilation: 15-20 air exchanges/hour
Enrichment: Rodents were housed with deep wood sawdust bedding to allow digging and other normal rodent activities.The temperature and relative humidity were recorded twice daily during the acclimatisation period and throughout the study.
Food and Water Supply: Animals received ssniff® SM R/M "Autoclavable complete diet for rats and mice – breeding and maintenance" produced by ssniff Spezialdiäten GmbH, D-59494 Soest Germany (Batch No.: 278 5652, expiry date: 30 November 2016), ad libitum, and tap water from the municipal supply, as for human consumption from a 500 ml bottle, ad libitum.
Animal Identification:Animals were individually identified using numbers written on the tail with an indelible marker pen. The numbers were given on the basis of CiToxLAB Hungary Ltd.' s Master File, for each animal allocated to the treatment groups. The cages were identified by cards, with information about study code, sex, dose group, cage number and individual animal numbers.

Type of coverage:

occlusive

Vehicle:

unchanged (no vehicle)

Details on dermal exposure:

The back of each animal was shaved (approximately 10% area of the total body surface) approximately 24 hours prior to treatment. The test item was applied as a single dose to the shaved skin and remained in contact with the skin for the 24-hour exposure period. Sterile gauze pads were placed on the skin of rats to cover the test item. These gauze pads were kept in contact with the skin using a patch with adhesive hypoallergenic plaster. The entire trunk of the animal was then wrapped with semi occlusive plastic wrap for 24 hours.At the end of the exposure period, the area of skin treated with the test item was washed with water of body temperature.

Duration of exposure:

24 hours

Doses:

Doses
Justification of the doses:The test item was not expected to be lethal at 2000 mg/kg body weight (bw). A limit test was therefore performed at 2000 mg Sodium methanesulfonate /kg bw (equivalent to 4.23 mL/kg bw of SPS10LS, based on the analytics performed on 27 May 2016).A single dermal application was made and was followed by a 14-day observation period.

No. of animals per sex per dose:

5 males and 5 females

Control animals:

not required

Details on study design:

OBSERVATIONS
Clinical Observations
Clinical observations were performed on the day of treatment at 1 and 5 hours after application of the test item and once each day for 14 days thereafter.Observations included the skin and fur, eyes and mucous membranes, the respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
Skin Irritation:Adverse skin reactions at the site of application were recorded daily following the removal of the dressing.
Body Weight Measurement: The body weights were recorded on Day 0 (before test item administration) and on Days 7 and 14 just before necropsy.
NECROPSY
Macroscopic examination was performed on all animals. The animals were sacrificed by exsanguination under pentobarbital anaesthesia (Euthanimal 40%; Lot No.: 1409236-06, Expiry Date: September 2017, Produced by: AlfasanNederland BV, Woerden, Netherlands). After examination of the external appearance, the cranial, thoracic and the abdominal cavities were opened and the organs and the tissues were observed. Macroscopic abnormalities were recorded.

Statistics:

Not specified

Key result

Sex:

male/female

Dose descriptor:

LD0

Effect level:

>= 2 000 mg/kg bw

Based on:

test mat.

Mortality:

Sodium methanesulfonate did not cause mortality at the dose level of 2000 mg/kg bw.

Clinical signs:

There were no systemic clinical signs noted in any animal throughout the study.

Body weight:

Body weight gains of Sodium methanesulfonate treated animals during the study showed no indication of a test item-related effect.

Gross pathology:

There was no evidence of the macroscopic observations at a dose level of 2000 mg/kg bw.

Other findings:

No further findings specified in the study report.

CLINICAL OBSERVATIONS

DOSE LEVEL: 2000 mg/kg bw

SEX: Male

Cage No.

Animal No.

Observations

Observation days

Frequency

1777

Symptom Free

16/16

1778

Symptom Free

16/16

1779

Symptom Free

16/16

1780

Symptom Free

16/16

1781

Symptom Free

16/16

DOSE LEVEL: 2000 mg/kg bw

SEX: Female

Cage No.

Animal No.

Observations

Observations days

Frequency

1782

Symptom Free

16/16

1783

Symptom Free

16/16

1784

Symptom Free

16/16

1785

Symptom Free

16/16

1786

Symptom Free

16/16

Remarks:

+ = present

h = hour (s)

Treatment day = Day 0

Frequency of observation = number of occurrence of observation / total number of observations

BODY WEIGHT DATA

DOSE LEVEL: 2000 mg/kg bw						SEX: Male
Cage No.	Animal No.	Body weight (g) Days			Body Weight Gain (g)
Cage No.	Animal No.	0	7	14	0-7	7-14	0-14
1	1777	235	299	363	64	64	128
2	1778	217	277	324	60	47	107
3	1779	244	304	364	60	60	120
4	1780	245	306	358	61	52	113
5	1781	250	318	377	68	59	127
Mean:		238.2	300.8	357.2	62.6	56.4	119.0
Standard deviation:		13.0	15.0	19.8	3.4	6.8	9.0

DOSE LEVEL: 2000 mg/kg bw						SEX: Female
Cage No.	Animal No.	Body weight (g) Days			Body Weight Gain (g)
Cage No.	Animal No.	0	7	14	0-7	7-14	0-14
6	1782	224	227	242	3	15	18
7	1783	218	256	275	38	19	57
8	1784	226	241	258	15	17	32
9	1785	220	245	266	25	21	46
10	1786	231	259	271	28	12	40
Mean:		223.8	245.6	262.4	21.8	16.8	38.6
Standard deviation:		5.1	12.8	13.0	13.3	3.5	14.7

NECROPSY FINDINGS

DOSE LEVEL: 2000 mg/kg bw					SEX: Male
Cage No.	Animal No.	Necropsy Date/ Necropsy Day	External Observations	Internal Observations	Organ/Tissue
1	1777	02 August 2016 Day 14	No external observations	No internal observations	Not applicable
2	1778	02 August 2016 Day 14	No external observations	No internal observations	Not applicable
3	1779	02 August 2016 Day 14	No external observations	No internal observations	Not applicable
4	1780	02 August 2016 Day 14	No external observations	No internal observations	Not applicable
5	1781	02 August 2016 Day 14	No external observations	No internal observations	Not applicable

DOSE LEVEL: 2000 mg/kg bw					SEX: Female
Cage No.	Animal No.	Necropsy Date/ Necropsy Day	External Observations	Internal Observations	Organ/Tissue
6	1782	02 August 2016 Day 14	No external observations	No external observations	Not applicable
7	1783	02 August 2016 Day 14	No external observations	No external observations	Not applicable
8	1784	02 August 2016 Day 14	No external observations	No external observations	Not applicable
9	1785	02 August 2016 Day 14	No external observations	No external observations	Not applicable
10	1786	02 August 2016 Day 14	No external observations	No external observations	Not applicable

Interpretation of results:

GHS criteria not met

Conclusions:

The acute dermal lethal dose (LD0 value) of the test item Sodium methanesulfonate was found to be equal to or above 2000 mg/kg bw in male and female Crl:WI rats

Executive summary:

Under the conditions of this study, the acute dermal lethal dose (LD0 value) of the test item Sodium methanesulfonate was found to be equal to or above 2000 mg/kg bw in male and female Crl:WI rats.

Endpoint conclusion

Endpoint conclusion:: no adverse effect observed
Dose descriptor:: discriminating dose
Value:: 2 000 mg/kg bw

Additional information

Justification for classification or non-classification

No classification is warranted.

Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.